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Some Permanent Hearing Loss is Missed When “Switched Ear”
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Abstract: In practice, some Newborn Hearing Screening (NHS) programs designate an infant as having a bilateral “pass”
by using non-simultaneous results obtained in each ear during different screening sessions (referred to in this article
as switched ears or SW_EAR). This study aims to obtain evidence for determining the screening outcome of infants
with SW_EAR, using data from MEDNAX-Pediatrix’s nationwide NHS program. From January 2009 to December 2012,
infants with SW_EAR passes were referred for audiological evaluation. The audiological evaluations of 13,044 infants
who referred (1,907 due to SW_EAR passes) out of the total infant population screened (2,212,107) were analyzed. Of
the 2,816 infants identified with permanent hearing loss (PHL), 150 (5.3%) were from the group of infants with SW_EAR
passes. Most of these infants (116/150, 77%) had bilateral PHL, with documented hearing aids in 89 infants and 7 infants
who received cochlear implants. By not using SW_EAR passes (i.e., by not combining non-simultaneous ear passes from
different screening sessions) to determine that the infant had passed the newborn screen, and instead referring those
infants for audiological evaluation, a significant number of infants with PHL were identified, while maintaining program
performance within benchmarks.
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Introduction
Over the last two decades Newborn Hearing Screening
(NHS) programs have evolved and are being developed
in many countries worldwide. As a result, the focus and
challenges of NHS have shifted from implementing
programs to creating more efficient and effective
screening practices (Choo & Meinzen-Derr, 2010; Nelson,
Bougatsos, & Nygren, 2008; White, Forsman, Eichwald, &
Muñoz, 2010).
Major challenges for successful and cost-efficient
screening practices include the need to maintain
sufficiently low referral and false positive rates. The

use of repeat screening tests/sessions with automated
auditory brainstem response (AABR) and/or otoacoustic
emissions (OAE) technology has proven to be a useful
approach to achieve these goals (Clemens & Davis, 2001;
Gravel et al., 2005; Vohr et al., 2001; White et al., 2005).
A number of well-controlled studies have demonstrated
that the commonly used two-step/two-technology NHS
protocols can effectively reduce the overall referral rates to
≤ 4% of the total infants screened or even lower for those
protocols that combine inpatient (IP) and outpatient (OP)
screens (Thompson et al., 2001). However, while repeated
automated screens help to enhance specificity by reducing
false positive results (Clemens & Davis, 2001), they could
take a toll on the protocol sensitivity and cause more
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infants with hearing loss to pass the screen (an increase
of false negatives) due to inherent problems of statistical
artifacts associated with repeated testing (JCIH, 2007, p.
903).
It is important to systematically evaluate the various factors
that could impact the overall performance of repeat testing
NHS protocols. Recent studies by Turner (2013a, 2013b),
using mathematical modeling and receiver operating
characteristics (ROC) methodology, identified complex
interactions between three basic factors that could
enhance or reduce below optimum the overall performance
of NHS protocols using repeat automated screens: (a)
the accuracy of the screening test/technology in use, (b)
the internal test correlation measuring the likelihood that
repeated screens identify the same individuals as positive
(refer) or negative (pass), and (c) the protocol’s stopping
criterion by which the results from repeat screens are
combined to make the final pass/refer decision for the
infant.
Past studies of NHS have focused on the overall
efficiency/effectiveness of the most commonly
implemented protocols (Gravel et al., 2005; White et al.,
2005) or compared the accuracy of the screening method
(OAE vs. AABR) in use (Norton et al., 2000). However,
there is limited data available from NHS programs
regarding the consequences of repeated automated
screens or the criteria by which the results from multiple
screens are used to determine the pass/refer outcome
for an infant. As a result, there is a limited understanding
of the impact these internal decisions may have on the
overall performance of the screening protocol being used.
This knowledge, when available, may provide a rational
basis for further enhancements of NHS programs.
A key aspect in the implementation of NHS protocols,
regardless of the technology being used, is how results
from multiple automated screens are used to make a
final pass/refer decision for an infant. The Expert Panel
Recommendations on Newborn Hearing Screening of the
American Speech-Language-Hearing Association (ASHA,
2013) state: “…. the infant must pass the screening in both
ears to be considered a “pass”. The Recommendations
also state “… If the newborn fails one ear, both ears must
be screened during the re-screening”… (ASHA, 2013).
In this context, the interpretation of passing results in both
ears, which were obtained at a different test session or on
a different day, poses an interesting problem that needs
further investigation. There are no agreed-upon criteria for
deciding how to use ear passes in both ears that were not
obtained within the same test time or session.
Some Newborn Hearing Screening (NHS) programs
combine a pass result obtained for the left ear during one
test session with a pass result obtained for the right ear
during a different test session to conclude that the infant
has a bilateral pass for the hearing screen even though
both ears did not pass during the same test session.

Unfortunately, it is not known how many infants with PHL
may be missed by considering non-simultaneous passes
obtained in each ear during repeated screens (referred to
in this article as switched ears or SW_EAR passes) as a
bilateral “pass.” By this practice, an infant who passes only
one ear (left or right) during a screen session and then
during a repeat screen performed at a different test time or
on a different day passes the ear that previously referred,
would be given a “pass-pass” or screen negative outcome.
However, there is no systematic research to whether the
use of such SW_EAR passes may result in infants with
permanent hearing loss being missed.
Method
Study Design
A retrospective cross-sectional study compared hearing
screen results and audiological outcome data collected
from January 2009 to December 2012 by MEDNAXPediatrix’s nationwide NHS program (PDX_NHS) using
AABR technology. Out of the total infant population
screened (2,212,107), infants who received a refer
status at discharge (13,044) were categorized into two
groups: (a) those with SW_EAR passes (1,907) and (b)
those without SW_EAR passes (11,137).
Inclusion/Exclusion Criteria. During the four years in
which data were collected for this study, PDX_NHS
programs referred all infants with SW_EAR passes for
a complete audiological follow-up. The hearing screen
data and audiological evaluations were categorized
into two groups (with and without SW_EAR passes) as
described below.
Infants with SW_EAR Passes. This group included
those infants who had non-simultaneous passing results
which were obtained in each ear during a repeat screen
performed at a different time or on a different day. The
“switching” between left ear and right ears passes could
have occurred during any of the screens performed
prior to discharge (inpatient) or when recalled as an
outpatient. These infants would have been considered a
“pass” (screen negative result) prior to this study. Figure
1 illustrates an example of an SW_EAR pass result for
an infant with three repeat inpatient screens.
Infants without SW_EAR Passes. The group included
those infants who failed one or both ears during the
final AABR screen performed, prior to discharge as an
inpatient (IP) and/or when recalled as an outpatient
(OP), who had no “switching” between left and right ear
passes during any combination of the screens or test
sessions performed.
Participants. The study included all infants who
received a refer status (13,044 in total; 1,907 with
SW_EAR passes) during the four-year study period
(2009–2012). The total number of infants screened by
PDX_NHS programs during this time was 2,212,107,
which represented 99.9% of all eligible births from 320
hospitals in 29 states.
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Hearing Screen #1 (1/27/2011)
Right Ear: PASS

Left Ear: REFER

Decibel Level: 35
Hearing Screen #2 (1/27/2011)
Right Ear: REFER
Left Ear: REFER

Decibel Level: 35
Hearing Screen #3 (1/29/2011)
Right Ear: REFER
Left Ear: PASS

Decibel Level: 35

Figure 1. A typical example of SW_EAR hearing screen results. Three screens were performed, each at a different time
or test session. Conflicting passing results in each ear (SW_
EAR) were obtained during screen #1 and screen #3. These
non-simultaneous passes for the Left and Right ear would be
combined as a Pass-Pass or screen negative outcome for the
infant if SW_EAR pass results are allowed.
Screening Protocol. The protocol combined IP and
OP AABR hearing screens (when allowable per state
specific guidelines) in most facilities. During the study
period, the PDX_NHS screening protocol limited the
number of AABR screens that could be performed for
any infant to a maximum of three repeat screens during
the IP stage (prior to discharge) and no more than two
additional screens if recalled for OP testing session.
Equipment. All PDX_NHS programs used AABR as the
method for screening with equipment manufactured,
and approved for use, in the USA. However, the specific
AABR testing device/model varied across hospitals from
2009–2011 and included ALGO® screeners (models
ALGO 2E®, ALGO 2EC®, AlGO3®) and Bio-Logic
ABaer® systems manufactured by Natus Medical Inc.,
as well as, Smart Screener-Plus 2® manufactured
by Intelligent Hearing Systems. Specifications for
each product are provided in the Hearing Review
Products Technology Guides (2012) on the National
Center for Hearing Assessment and Management
(NCHAM) website. To facilitate program and operational
standardization, a conversion to a single manufacturer
of automated screening devices (Intelligent Hearing
Systems, Smart Screener-Plus 2®) was initiated
beginning in 2010 and completed by the end of 2011.
Data Collection. Demographic information of all infants
screened by PDX_NHS program during the study, each
infant’s screening results, audiological evaluations,
and information about use of hearing technology for all
infants who were referred from the hearing screening
in each group (with and without SW_EAR passes)
was maintained in a web-based tracking and database
management system (Soundata®). Referred infants
who failed the audiological testing were followed for
two years to capture as much diagnostic and hearing
technology data as possible.

Data Audit. The diagnoses/outcomes data maintained
in Soundata® for the infants who were referred at
follow-up were audited independently by two authors
to validate the audiological evaluations data used in
this study. The authors specifically focused on the
manual entry of the results from different Audiology/
ENT reports. Different queries were posed to crosscheck the data for inconsistencies in the results and/or
inconclusive outcomes/diagnoses. Any detected cases
were reviewed and corrected prior to final data analysis.
Since a separate diagnostic category for fluctuating or
temporary hearing loss due to middle ear pathology
was not available for data categorization during the
initial stage of the study, a full case-by-case review
was conducted of all referred infants categorized as
conductive hearing loss and/or middle ear disorder(s).
Lastly, all cases in the SW_EAR group with a diagnosis
of PHL, as well as those documented as receiving
hearing technology (e.g., cochlear implants and/or
hearing aids) were reviewed case-by-case and updated/
corrected as needed.
Data Analysis. Upon completion of the data auditing
process, the audiological outcome data of all referred
infants in the study sample (with and without SW_EAR
passes) were analyzed. Data analyses included
descriptive and nonparametric statistics.
Audiological outcomes data. Infants who were
referred during screening (with and without SW_EAR)
were categorized as follows:
Permanent Hearing Loss (PHL). Included infants
with unilateral or bilateral hearing loss of any of the
following diagnosis/types: Sensorineural hearing
losses (SNHL); Auditory Neuropathy Spectrum
Disorder (ANSD); Permanent Conductive hearing
loss (PCHL), and mixed hearing loss.
Fluctuating Conductive Hearing Losses (FCHL).
Included infants whose only hearing loss was
attributable to temporary or fluctuating unilateral
or bilateral conductive hearing loss, due to middle
ear pathology which was evidenced through repeat
audiological testing and/or following medical
intervention (e.g., pressure equalization tubes or
medical treatment).
Inconclusive Diagnosis. Included infants who
failed follow-up testing with abnormal diagnostic
tests and/or rescreen results, but had insufficient
data to reach a definitive audiological diagnosis (i.e.,
type and/or degree of hearing loss in each ear).
No Hearing Loss. Included all infants who passed
the follow-up audiological testing in both ears.
Passing results could be obtained with either
automated screening tests alone (e.g., OAE, AABR)
or were produced via a complete or incomplete
diagnostic test battery (e.g., diagnostic ABR
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thresholds and/or behavioral testing) as well as
other audiological tests.
Program Performance Metrics. Appropriate actions
for SW_EAR results within PDX_NHS program were
determined by calculating the following metrics of the
program during the study period and expressed as
percentages:
Referral Rates: number of refers in each group
divided by the number of infants screened
Permanent Hearing Loss Rate among Referrals:
number of infants who had a definitive diagnosis
of PHL (e.g. sensorineural, conductive, mixed and
ANSD) unilateral or bilateral in each group, divided
by the number of infants referred for audiological
follow-up
No Hearing Loss Rate among Referrals: number
of refer infants who had passing results during the
audiological follow-up testing and no temporary
hearing loss evidenced during the follow-up period
in each group, divided by the total infants who were
referred for audiological follow-up
Diagnosed PHL: number of infants who had a
definitive diagnosis of PHL in each group (e.g.,
SNHL, PCHL, mixed, and ANSD) unilateral or
bilateral, divided by the total number of infants
screened
False Positives: number of infants determined
to have normal hearing who failed the hearing
screening, divided by the number of infants
screened
Results
Figure 2 shows the results for hearing screen data
and audiological diagnostic evaluation of infants who
received a refer status in both groups: (a) without SW_
EAR passes and (b) with SW_EAR passes. Seventyseven percent of the infants who referred in each
group during the period of the study (2009–2012) were
successfully tracked and had Audiology/ENT reports in
Soundata®.
Most of the infants who were successfully tracked
had sufficient follow-up data (e.g., Audiology/ENT
reports, test results, and/or information about use of
hearing technology) for a definitive diagnosis and could
be categorized as either: (a) PHL (including SNHL,
PCHL, mixed or ANSD), (b) FCHL due to transient or
chronic middle ear pathology, or (c) no hearing loss.
However, there were a few infants who failed the initial
diagnostic testing but had insufficient follow-up data for
determining the nature of the hearing loss and were
therefore categorized as inconclusive and omitted from
further analysis (4.7% of those with SW_EAR passes).

Of the 1,907 infants in the group of infants with
SW_EAR passes (Figure 2), 150 infants (7.9%) were
diagnosed with PHL including SNHL, ANSD, PCHL, or
mixed hearing loss. Note that the infants with SW_EAR
passes constituted 14.6% (1907/13,044) of the total
infants referred for audiological follow-up. The infants
with SW_EAR passes who were diagnosed with PHL
represented 5.3% (150/2,816) of those diagnosed with
PHL in the population of 2,212,107 infants that were
screened. Interestingly, in the group of infants with
SW_EAR passes (1,907 infants) the proportion of PHL
identified (150/1907, 7.9%) was higher than the PHL
diagnosed in those infants screened who had no SW_
EAR passes (2,666/2,210,200, 0.12%).
To further validate the audiological diagnosis of PHL,
data were analyzed for the 183 infants in the group with
SW_EAR passes who had documented use of hearing
technology in Soundata® during the follow-up period.
There were 89 infants diagnosed with PHL in the group
with SW_EAR passes who were fit with hearing aids
and 7 infants (6 SNHL, 1 ANSD) who received cochlear
implants.
The type and degree of hearing loss was reviewed for
each of the infants diagnosed with PHL in the group
with SW_EAR passes. Three quarters of these had both
ears affected (116/150, 77.3%). The severity of PHL
for the total number of ears affected (N = 266 ears) is
shown in Figure 3.
Note that about half of the infants’ ears with PHL
(52.6%, 140/266) had moderate-to-severe or severeto-profound hearing loss. Also, 61% (42/70 ears) of
the total ears which were classified as mild or mild-tomoderate PHL were fit with hearing aids. The frequency
distribution by type of hearing loss diagnosed in both
groups (with and without SW_EAR passes) is shown in
Figure 4.
Fluctuating conductive hearing loss due to temporary
and/or chronic middle ear disorders was more
frequently diagnosed in the group with SW_EAR passes
than in the group without SW_EAR passes (Chi square
= 71.65; p < 0.000). Also, the proportion of PCHL was
lower in the group with SW_EAR passes compared
to the group without SW_EAR passes (Chi square
= 16.59; p < 0.000). Given that PDX_NHS policies
stipulated that infants with ear atresia should not be
screened, but should be referred directly for audiological
follow-up, PCHL secondary to ear atresia/microtia was
not represented in the group with SW_EAR passes.
The remaining types of PHL showed similar frequency
distributions for refer infants with and without SW_EAR
passes (SNHL: Chi Square = 3.19; p < 0.07; ANSD: Chi
Square = 1.56; p < 0.21; Mixed: Chi Square
= 1.10; p < 0.29).
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Total Screened
(2,212,107)

Refer Status at
Discharge
(13,044)

SW_Ear
(nonsimultaneous ear
passes)
(1,907)

Without
SW_EAR
(11,137)

No Hearing
Loss
(4,545; 40.8%)

Permanent
Hearing Loss
(2,666; 23.9%)

Arrived at
Audio/ENT for
Follow-Up
(8,587; 77.1%

Lost to
Follow-Up
(2,550; 22.9%)

Lost to
Follow-Up
(445; 23.3%)

Arrived at
Audio/ENT for
Follow-UP
(1462; 76.7%)

Dx Hearing
Loss
(3,414; 30.6%)

Inconclusive
Diagnosis
(628; 5.6%)

Inconclusive
Diagnosis
(89; 4.7%)

No Hearing
Loss
(1,060; 55.6%)

Fluctuating
Conductive
Hearing Loss
(748; 6.7%)

Fluctuating
Conductive
Hearing Loss
(163; 8.5%)

Hearing Loss
(313; 16.4%)

Permanent
Hearing Loss
(150; 7.9%)

Figure 2. Flowchart summarizing the hearing screen data and audiological diagnostic outcomes of the infants who received a
refer status in both groups: (a) without SW_EAR and (b) with SW_EAR passes. Lost to Follow-up category includes all refer
infants that were lost (no audiological follow-up) including those unsuccessfully tracked as well as the parents/physician refusals, ineligibles due to medical constraints, etc.
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Finally, selected metrics of program performance were
analyzed for the group of infants without SW_EAR
passes and for all infants in the sample (see Table
1). Note that the addition of the group with SW_EAR
passes allowed the identification of an average of one
more infant with PHL in every hundred with positive
screening results (PHL rates increased from 21.7% for
infants without SW_EAR to 22.9% when infants with
SW_EAR passes were referred for audiological followup). Also, there was a slight increase in the referral
rates (from 0.50% to 0.58%, as well as in the proportion
of infants with no HL (from 34.8% to 42.9%).

66, 25%

74, 28%

36, 13%
56, 21%
34, 19%

Discussion

Mild

Moderate Severe

Mild-Moderate

Severe-Profound

Moderate

Figure 3. Severity of permanent hearing loss (PHL) diagnosed in infants with SW_EAR passes. (Total number of ears
affected (N = 266).

100%

80%

The need for systematic evaluation and monitoring
of NHS program performance has been recognized
as an important area for clinical research (White,
Forsman, Eichwald, & Muñoz, 2010, ASHA, 2013).
This population-based study, conducted within the
context of PDX_NHS nationwide program provides
convincing evidence that a significant number of infants
with permanent hearing loss will be missed if infants
with SW_EAR passes are not referred for audiological
evaluation. Furthermore, results constitute strong
empirical support for the current NHS recommendations
(ASHA, 2013) that both ears must pass the screening
for an infant to be screened negative. In addition, it
supports clarification of the recommendation that both
ear passes must be obtained during the same test time
or during the same session.
Evidence from the retrospective analysis of diagnostic
audiological evaluations collected during a four-year
period (2009–2012) for 13,044 referred infants (of
which 1,907 infants had SW_EAR passes) out of the

60%

Table 1
Impact of referring infants with SW_EAR passes on the
performance of PDX_NHS program

40%

20%

0%
SNHL

PCHL*

MIXED

Without Switched Ears

ANSD

FCHL*

Switched Ears

Figure 4. Type of permanent hearing loss (PHL) identified in
infants with and without non-simultaneous passes obtained
in each ear during different screening sessions (SW_EAR).
Note. ANSD = auditory neuropathy spectrum disorder; FCHL = fluctuating conductive
hearing loss; MIXED = mixed hearing loss; PCHL = permanent conductive hearing
loss; SNHL = sensorineural hearing loss.
* Indicates statistical significance (p < 0.05) between infants referred with SW_EAR
and without SW_EAR.

Screening Metrics

Infants without SW_EAR
passes (n = 2,210,200)

All infants in sample
(N = 2,212,107)

Referral Rates

0.50 [0.44-0.55]

0.58 [0.50-0.65]

No HL Rate

33.8 [31.8-35.9]

41.2 [37.8-44.6]

PHL Rate

21.7 [19.5-23.7]

22.9 [20.7-25.1]

False Positive

0.20 [0.16-0.23]

0.24 [0.2-0.3]

Permanent HL

0.12 [0.11-0.12]

0.13 [0.12-0.14]

Note. Data based on quarterly estimates for each metric calculated across sites
(320 hospitals in 29 states) during the four years study (2009–2012). HL = hearing
loss; PHL = permanent hearing loss; PDX_NHS = MEDNEX-Pediatrix newborn
hearing screening; SW_EAR passes = non-simultaneous passes obtained in each
ear during different screening sessions.
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total population screened (2,212,107) showed that by
completing the audiological follow-up on infants with
SW_EAR passes, PDX_NHS program identified one
more infant with PHL in every hundred infants who were
referred from the newborn hearing screening program.
The infants in group of SW_EAR passes who were
diagnosed at follow-up with permanent hearing loss
(150/1,907, 7.3%) represent 5.3% of all infants identified
with PHL in this sample of 2,212,107 infants who were
screened. It is also important to note that the program
maintained very low referral rates (0.58%) even though
additional infants were being referred.
The hearing loss diagnosed in the group of children
with SW_EAR passes should be further analyzed. Most
of these infants diagnosed with PHL (116/150, 77%)
had bilateral hearing losses and about half of these
infants’ ears (52%, 140/266) had moderate-to-severe or
severe-to-profound hearing losses. In addition, a high
proportion of infants with SW_EAR passes (136/1,907,
8.5%) were diagnosed with fluctuating conductive
hearing losses (FCHL) due to middle ear effusion. This
type of dysfunction could “switch” from one ear to the
other, and be reflected in non-simultaneous ear passing
results at different test times. An elevated incidence
of temporary middle ear dysfunction in the neonatal
period associated with the development of middle
ear pathology has been well documented by many
authors (Doyle, Kong, Strobel, Dallaire, & Ray, 2004;
Doyle, Rodgers, Fujikawa, & Newman, 2000). The fact
that the relative proportion of FCHL was significantly
higher in the infants with SW_EAR passes compared
to those without SW_EAR passes is consistent with the
hypothesis that middle ear pathology may be a plausible
explanation for part of the hearing loss diagnosed in the
SW_EAR group.
Another possible explanation for the hearing losses
identified in infants with SW_EAR passes that should
be analyzed is the problems associated with the use
of automated screening technology. There are many
operational factors that may affect screening results
(e.g., accuracy of earphone placement, artifacts due
to baby movement, environmental noise, etc.) as well
as technical issues (e.g., problems of repeat screening
attempts and lack of standardization of automated
screening technology). Although these issues have
been mentioned in the literature (JCIH, 2007; ASHA,
2013), they have not been adequately explored.
One limitation of this study is that different types of
AABR equipment were used during the study. Given
that each type of equipment/manufacturer uses different
algorithms for determining the pass/refer decision in
any single screen performed, the likelihood of an infant
having SW_EAR passes might vary for the different
devices. This possibility needs to be explored with all
types of AABR manufactured equipment. Also, the
possibility that similar results would be obtained with
OAE equipment needs to be investigated.

Another limitation of the study is the number of repeat
automated screens that were performed for determining
the final outcome for an infant. During this period of the
study, up to five screens (3 IP + 2 OP) were allowed. As
more screens are performed, the statistical problems of
sequential testing (Stürzebecher, Cebulla, & Elberling,
2005; Stürzebecher & Cebulla, 2013) may increase the
probability of falsely passing PHL, but this needs to be
investigated.
The implications of this study for clinical practice are
important. Current best practice guidelines state that
both ears should pass for an infant to pass the screen
(ASHA, 2013). Also, the recommendations state that
both ears must be tested during re-screening. The
empirical data provided in this study supports the above
recommendations and indicates that both ears should
pass within the same screening session for an infant
to be considered a pass (screen negative outcome).
The fact that PHL, mostly bilateral and of significant
magnitude, was diagnosed in this group, suggests that
infants with non-simultaneous ear passes should be
referred and tracked for audiological follow-up with the
same urgency as repeat “non-switching” unilateral or
bilateral refers.
The results of this study also demand refocused
attention on how parents are counseled regarding
SW_EAR results by screeners, pediatricians, and
audiologists. Providers should not suggest that because
a pass result was obtained for both ears, albeit at
different times, that the diagnostic evaluation is likely
to result in a conclusion that the infant has normal
hearing. Indeed only 55.6% of the 1,907 infants who
had SW_EAR passes were determined to have normal
hearing, with the remainder being diagnosed with
PHL (7.9%) or conductive hearing loss (CHL; 8.5%),
having inconclusive results (4.7%), or not returning
for the audiological evaluation (23.3%). These data
suggest that if providers minimize the importance of
parents completing diagnostic follow-up testing, there
is a real possibility of missing infants with permanent
and conductive hearing loss with a consequential
detrimental effect for infant development (YoshinagaItano, Coulter, & Thomson, 2001).
Conclusion
This retrospective study of 2,212,107 screened
infants, 1,907 of whom had SW_EAR passes, provides
evidence for eliminating the practice of passing infants
by combining “switched ear” passes from repeat
screens and therefore missing potential permanent
hearing loss. Results support the current ASHA best
practice recommendation which requires both ears
to pass the screening for an infant to be screened
negative with the added specification that both ear
passes should be obtained within the same screening
session.Furthermore, all hearing health care providers
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involved in clinical follow-up care of refer infants should
be cautious about concluding that an infant has normal
hearing based on non-simultaneous passes on each ear
from repeat screens.
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